BMO Capital Reiterates Outperform Rating on Pfizer (PFE)
Go back to BMO Capital Reiterates Outperform Rating on Pfizer (PFE)| Pfizer Inc. (NYSE: PFE) | Delayed: 26.32 +0.72 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.60 | 52 Week High | $37.39 | |||
| Open | $25.79 | 52 Week Low | $28.25 | |||
| Day High | $26.48 | P/E | 15.95 | |||
| Day Low | $25.79 | EPS | $1.65 | |||
| Volume | 30,650,939 | |||||
